What is the market doing?
What the tape says about CRVS
Corvus Pharmaceuticals, Inc. is +161% over the past year while the S&P 500 is +20%: 141 points ahead of the market.
+161%
1-year return · S&P 500 +20%
- vs 200-day average
- +3.8%
vs 200-day average · close to trend
- RSI (14)
- 40
RSI (14) · neutral
- Below its 52-week high
- 45%
Below its 52-week high
Details›
- Last close2026-09-08
- $13.91
- 1 monthS&P 500 −0.30%
- +0.29%
- 1 yearS&P 500 +20%
- +161%
- 5 yearsS&P 500 +85%
- +582%
- vs 50-day average$13.78
- +0.93%
- 52-week high
- $25.52
- 52-week low
- $5.19
- Annualised volatility
- 142%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $334K
| Year | Return |
|---|---|
| 2026 (year to date) | +81% |
| 2025 | +44% |
| 2024 | +204% |
| 2023 | +107% |
| 2022 | −65% |
| 2021 | −32% |
| 2020 | −35% |
| 2019 | +48% |
| 2018 | −65% |
| 2017 | −28% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +15% |
| Feb | 10 | 3 of 10 | −6.1% |
| Mar | 10 | 3 of 10 | −2.6% |
| Apr | 10 | 5 of 10 | −5.5% |
| May | 10 | 6 of 10 | +26% |
| Jun | 10 | 3 of 10 | −5.9% |
| Jul | 11 | 6 of 11 | +5.1% |
| Aug | 11 | 8 of 11 | +14% |
| Sep | 11 | 5 of 11 | +9.6% |
| Oct | 10 | 4 of 10 | +1.8% |
| Nov | 10 | 6 of 10 | +0.43% |
| Dec | 10 | 2 of 10 | −6.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.